Back to Markets
INInovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc

INONASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$1.28

-0.030000 (-2.29%)

As of 4:00 PM EDT · USD

Compare
Low: $1.03Current: $1.28High: $2.98

Key Statistics

Open

$1.30

Day High

$1.30

Day Low

$1.26

Prev. Close

$1.31

VolumeShares traded today.

1.70M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$105.31M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-0.75

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$2.98

52W LowLowest price over the past 52 weeks.

$1.03

50D MAAverage closing price over the last 50 trading days.

$1.29

200D MAAverage closing price over the last 200 trading days.

$1.85

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-1.5%

1M

+17.0%

6M

-27.6%

YTD

-22.5%

1Y

-37.6%

About

Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.

www.inovio.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade INO

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.